EntryPoint Capital’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,776
Closed -$274K 780
2025
Q2
$274K Sell
12,776
-1,670
-12% -$36.1K 0.14% 326
2025
Q1
$356K Sell
14,446
-8,347
-37% -$206K 0.16% 239
2024
Q4
$528K Buy
+22,793
New +$570K 0.22% 89
2024
Q3
Sell
-2,066
Closed -$59.4K 885
2024
Q2
$59.4K Sell
2,066
-717
-26% -$22K 0.09% 504
2024
Q1
$81.2K Buy
2,783
+1,009
+57% +$28.2K 0.07% 528
2023
Q4
$57.7K Buy
+1,774
New +$51.4K 0.06% 644

Other funds holding KIDS

EntryPoint Capital's KIDS Position: Q3 2025 in Review

EntryPoint Capital sold out of OrthoPediatrics (KIDS) in Q3 2025, closing a stake of 12,776 shares — an estimated $274K sold.

EntryPoint Capital first reported a position in KIDS in Q4 2023 and held it in 6 quarters. The position peaked at $528K in Q4 2024. 111 funds tracked by Wall St. Rank hold KIDS as of Q3 2025.

  • EntryPoint Capital reported no remaining OrthoPediatrics position as of Q3 2025 after selling out during the quarter.
  • EntryPoint Capital sold 12,776 OrthoPediatrics shares in Q3 2025, an estimated $274K.
  • EntryPoint Capital first reported a position in OrthoPediatrics in Q4 2023 and held it in 6 quarters.
  • EntryPoint Capital's OrthoPediatrics position peaked at $528K in Q4 2024.
  • 111 funds tracked by Wall St. Rank held OrthoPediatrics as of Q3 2025.

Based on EntryPoint Capital's 13F filing for Q3 2025, filed 13 Nov 2025.